|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
FISH, PCPD Panel
Test Code902198
CPT Codes
88271 (x17), 88275 (x9)<br /> Restricted Client Code
Includes
FISH, Mantle Cell Lymphoma, IGH/CCND1, t(11;14)
FISH, NHL, BCL6 3q27 Rearrangement
FISH, ALL/NHL, MYC-BA, 8q24 Rearrangement
FISH, B-cell Malignancy, IGH, 14q32 Rearrangement
FISH, p53, Deletion 17p13.1
Chromosome FISH, D13S319, Deletion 13q14.3
FISH, Myeloma, Chromosomes CEP 9,11,15
FISH, Multiple Myeloma, 1q21
FISH, AML/MDS, -7/Deletion 7q31
Cytogenetics Communication
FISH, NHL, BCL6 3q27 Rearrangement
FISH, ALL/NHL, MYC-BA, 8q24 Rearrangement
FISH, B-cell Malignancy, IGH, 14q32 Rearrangement
FISH, p53, Deletion 17p13.1
Chromosome FISH, D13S319, Deletion 13q14.3
FISH, Myeloma, Chromosomes CEP 9,11,15
FISH, Multiple Myeloma, 1q21
FISH, AML/MDS, -7/Deletion 7q31
Cytogenetics Communication
Instructions
Please see the individual tests for specimen requirements, and stabilities.
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not reject.
Clinical history/reason for referral is required with test order. Prior therapy and transplant history should be provided with test order.
Specimen viability decreases during transit. Send specimen to testing lab for viability determination. Do not reject.
Methodology
Fluorescence In Situ Hybridization
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 8 days
Reference Range
See individual tests
